Search results for "mRNA manufacturing"
Article
mRNA: the messenger
Exploring the mRNA manufacturing universe? Proceed with confidence with some top tips from our scientists on mRNA synthesis and production. Watch the video to learn more about keeping the environ…
Article
Need solutions for large-scale production of mRNA-based molecules?
Therapies based on messenger RNA, such as mRNA vaccines, have revolutionary potential. mRNA therapeutics offer precise and individualized therapy and avoid manufacturing issues associated wit…
Article
Reducing the Risk of RNAse Contamination in mRNA Production
As drug and vaccine manufacturers work to optimize mRNA production processes, one hurdle to overcome is mRNA’s susceptibility to breakdown by ribonuclease (RNase) enzymes introduced during p…
Article
Increasing mRNA Capabilities and Capacity for Growing Market Needs
Click here to read more >>
The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.
Article
mRNA Processing Workflow for Vaccines and Therapeutics
CLICK HERE TO VIEW >>
Learn more on key considerations when setting up a messenger RNA (mRNA) process with this infographic.
Article
Concentrating Feed—an Applicable Approach to Improve Antibody Production
In this study, the authors evaluated different approaches to prepare highly concentrated feed media for fed-batch Chinese hamster ovary cell culture. By raising the pH or by adding surfactants, the fe…
Article
Accelerating the Development of mRNA Therapeutics
Manufacturing and processing challenges surrounding mRNA can be overcome in order to realize the true potential of a technology 30 years in the making.
READ FULL ARTICLE >>
Article
mRNA Vaccines: Current Trends and Perspectives
Read more >>
mRNA therapy is a rapidly growing field. The technology offers great benefit and potential for infectious diseases and personalized medicines due to its advantages in flexibility, co…
Article
Report from the 6th International HTPD Conference
The biggest challenge is still the people and Quantitative Structure-Activity Relationship (QSAR) plus mechanistic modeling were two key take-home messages from the 6th International conference devote…
Article
How can you harness the potential of nucleic acid therapeutics?
At Cytiva, the new team is here to support you. We can help you throughout the
development of your manufacturing workflow for oligonucleotides
and the purification of mRNA drug subs…